The Sri Lanka Pharmaceutical Manufacturers’ Association (SLPMA), in a historic step, issued a powerful national call to action urging all stakeholders to come together in a bold, unified effort to shape a future where Sri Lanka emerges
SLPMA
- Home
- Author: SLPMA
Warns domestic pharmaceutical production could collapse to 5% from current 25%Local manufacturers supply over 250 products, meeting 30 percent of government pharmaceutical needsStrengthening local pharmaceutical manufacturing “no longer an option” but “of national importance to ensure health
On July 11, 2025, SLPMA unveiled the “National Call to Produce Medicine in Sri Lanka—with Care, Trust, and Unity” at its AGM held at the Galle Face Hotel. The proposal presented:🔹 A strong national rationale🔹 A bold, future-ready
Strategies and policy recommendations to follow situational analysisfacilitated by ADB and WHO on SL requestBy Kumudini Hettiarachchi Interactive and in-depth were the sessions on a matter of vital importance for Sri Lanka and its people recently – ensuring ‘medicine
Click HereClick HereClick HereClick Here Previous slide Next slide Download PDF Here
United States Food and Drug Administration (USFDA) officials visited YADEN LABORATORIES PRIVATE LIMITED, a modern, state-of-the-art sterile formulation finished dosage manufacturing facility located inside the Katunayake Export Processing Zone. The visit is part of their program in
Yaden Laboratories participated with outstanding success in Arab Health 2025 which was held from 27th to 30th January 2025 in prestigious Dubai World Trade Center. This convocation Arab Health, as Middle East’s largest and most important healthcare event, celebrated
Yaden Laboratories participated with outstanding success in Tecnosalud- International Health Fair 2022 which was held from 7th to 9th September 2022 in Lima Peru on its 16th convocation. It has been recognized for more than 20 years